Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Joint associations between gestational environmental chemical mixtures and child behavioral outcomes.

Environment international·2026
Same author

Sino-Canadian Healthy Life Trajectories Initiative in China: an economic evaluation protocol.

BMJ open·2026
Same author

Antenatal depressive symptoms impair offspring neurodevelopment by inducing maternal gut microbiota dysbiosis during pregnancy.

Gut microbes·2026
Same author

Early secondary outcome analysis in multi-phase randomised-controlled trials, a pragmatic approach: the Healthy Life Trajectories Initiative (HeLTI).

Trials·2026
Same author

Age-specific centiles for fibroblast growth factor 23 and its associations with mineral and bone metabolism in healthy children.

The Journal of steroid biochemistry and molecular biology·2026
Same author

Vitamin D supplementation and musculoskeletal injury risk in young men undergoing arduous training: a randomised placebo-controlled trial.

The British journal of nutrition·2026
Same journal

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Lancet (London, England)·2026
Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: Jun 21, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

ハイパーパラチロイド 症候群

William D Fraser1

  • 1Unit of Clinical Chemistry, School of Clinical Sciences, University of Liverpool, Liverpool, UK. w.d.fraser@liverpool.ac.uk

Lancet (London, England)
|July 15, 2009
PubMed
まとめ
この要約は機械生成です。

副甲状腺症は,副甲状腺が過度に活動し,ホルモンの不均衡を引き起こします. 治療の範囲は,一次性副甲状腺症の手術から,ビタミンD欠乏症や二次性の慢性腎臓病の管理に至ります.

さらに関連する動画

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

関連する実験動画

Last Updated: Jun 21, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

科学分野:

  • エンドクリノロジー エンドクリノロジー
  • ネフロロジーはネフロロジーを用います.
  • メタボリックボーン疾患

背景:

  • 副甲状腺症は,副甲状腺ホルモンの活性が増加したことから生じます.
  • 主要性副甲状腺症は,特に閉経後の女性では一般的です.
  • 二次性副甲状腺症は,しばしばビタミンD欠乏症や慢性腎臓病と関連しています.

研究 の 目的:

  • 主要および二次性副甲状腺症の原因と管理の見直しを行う.
  • 現在のおよび新興の治療戦略を強調する.
  • ビタミンD欠乏症とその役割の複雑さについて議論します.

主な方法:

  • ハイパーパラチロイド症の原因,診断,治療に関する文献レビュー.
  • 現在の医療・外科管理オプションの分析.
  • ビタミンD欠乏症の定義と治療における課題についての議論.

主要な成果:

  • 原発性副甲状腺症は,手術 (副甲状腺切除術) または医療療法 (ビスフォスフォネート,ホルモン置換,カルシミメティック) で治療できます.
  • ビタミンD欠乏症は,特に高齢者において,二次性副副甲状腺症の頻繁な原因です.
  • 慢性腎臓病における二次性副甲状腺症は,腎臓の骨疾患に寄与し,新しい治療法が出現しています.

結論:

  • 甲状腺症の管理は,タイプと重症度によって異なります.
  • 最小侵襲的外科手術は,一次性副甲状腺症の治療にますます使用されています.
  • 最適なビタミンD欠乏管理と,CKDにおける腎臓骨疾患に対処するために,さらなる研究が必要である.